Elite Pharmaceuticals (ELTP) EPS (Diluted) (2010 - 2026)
Elite Pharmaceuticals (ELTP) recorded EPS (Diluted) of $0.01 in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$0.01 a year earlier and down 67.7% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EPS (Diluted) (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' EPS (Diluted) came in at $0.05 as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at $0.04.
- Annual EPS (Diluted) has a five-year compound annual growth rate of 48.8% (FY2021 to FY2026).
- Across earlier fiscal years, EPS (Diluted) came in at $0.00 in FY2025, $0.02 in FY2024 (+458.9%), $0.00 in FY2023 (-60.1%) and $0.01 in FY2022 (+63.2%).
- Quarterly EPS (Diluted) has ranged from -$0.01 in fiscal Q2 2025 to $0.02 in fiscal Q3 2026 over the past five years.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 573.1% in fiscal Q2 2024, against a decline of 87.2% in fiscal Q1 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $0.02 (Q4 2026), $0.02 (Q3 2026) and $0.01 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -0.04 |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
API Access
Elite Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();